OLR1 and head and neck squamous cell carcinoma: The present study aims to evaluate the potential of OLR1 as a promising biomarker for predicting the prognosis and treatment efficacy of ICI, while also highlighting its association with the EMT process and cuproptosis resistance in HNSCC.